Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Gururaj J, Kolar"'
Autor:
Gururaj J, Kolar, Eric D, Valder
Publikováno v:
Southern medical journal. 113(10)
Autor:
Nabila Azad, Mir Rauf Subla, Syed Anjum Khan, Brian Bartlett, Gururaj J. Kolar, Subhraleena Das, Arnab Chowdhury, Patrick M. Wieruszewski, Nitesh K. Jain, Hanyin Wang, Jamil Taji
Publikováno v:
Chest
We report the case of an 88-year-old man with coronavirus disease 2019 (COVID-19) who presented with ARDS and septic shock. The patient had exquisite BP sensitivity to low-dose angiotensin II (Ang-2), allowing for rapid liberation from high-dose vaso
Association between serum IgE level and adverse clinical endpoints in primary sclerosing cholangitis
Autor:
James H. Tabibian, Gururaj J. Kolar, Keith D. Lindor, Jayant A. Talwalkar, Felicity Enders, Mohamad Imam
Publikováno v:
Annals of Hepatology, Vol 13, Iss 3, Pp 384-389 (2014)
Introduction. Primary sclerosing cholangitis (PSC) is an idiopathic hepatobiliary disorder associated with an increased risk for cholangiocarcinoma (CCA) and a median survival time of 12 years. Reliable predictors of CCA and other major adverse event
Autor:
Sharon C. Spence, Gururaj J. Kolar, Ernest P. Bouras, Alan R. Zinsmeister, Michael Camilleri, Keith Gottesdiener, Deborah Rhoten, Michael Ryks, Lawrence A. Szarka, Duane Burton, Maria I. Vazquez-Roque, Johanna Iturrino, Andres Acosta, Amy Boldingh
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 13(13)
Ghrelin receptors are located in the colon. Relamorelin is a pentapeptide selective agonist of ghrelin receptor 1a with gastric effects, but its effects in the colon are not known. We aimed to evaluate the effects of relamorelin on bowel movements (B
Publikováno v:
American family physician. 89(9)
Autor:
Patricia J. Erwin, Gururaj J. Kolar, Andrea Shin, Colin P. West, Michael Camilleri, Mohammad Hassan Murad
Publikováno v:
Alimentary pharmacologytherapeutics. 39(3)
Summary Background Highly selective 5-HT4 agonists have been suggested for the treatment of chronic constipation (CC). Aim To assess the effects of highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) on patient-important clinica
Publikováno v:
Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society. 26(1)
Background Nausea and vomiting are thought to result from upper gastrointestinal dysfunctions. Our clinical observations led to the hypothesis that colonic motor dysfunction is associated with nausea and vomiting. Methods We reviewed electronic medic
Autor:
G. Richard Locke, Gururaj J. Kolar
Publikováno v:
Irritable Bowel Syndrome: Diagnosis and Clinical Management
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62aa359aac2f9280f7701637e5301983
https://doi.org/10.1002/9781118444689.ch4
https://doi.org/10.1002/9781118444689.ch4
Autor:
Duane Burton, Michael Camilleri, Alan R. Zinsmeister, Maria I. Vazquez-Roque, Gururaj J. Kolar, Paula Carlson
Genetic variations in metabolism of endocannabinoids and in CNR1 (gene for cannabinoid 1 receptor) are associated with symptom phenotype, colonic transit, and left colon motility in irritable bowel syndrome (IBS). Our aim was to evaluate associations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a84613635c0d5e4f4fbe62ae2ba2bd86
https://europepmc.org/articles/PMC3602676/
https://europepmc.org/articles/PMC3602676/
Publikováno v:
American Journal of Gastroenterology. 110:S501